Top Growth Trends in the Microneedle Drug Delivery Systems Market: Key Insights and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the microneedle drug delivery systems market size evolved in recent years?
The market for microneedle drug delivery systems has been expanding quickly in the past few years. The market, which was valued at $5.01 billion in 2024, is projected to rise to $5.9 billion in 2025, with a compound annual growth rate (CAGR) of 17.9%. This growth during the historical period is linked to several aspects, including painless drug delivery, increased patient cooperative behavior, management of chronic diseases, cosmetic and aesthetic benefits, and vaccination administration.
What are the predictions for the microneedle drug delivery systems market size in the coming years?
The market size for microneedle drug delivery systems is projected to experience a significant increase in the coming years. It’s predicted to reach a value of $11.44 billion by 2029, with a compound annual growth rate (CAGR) of 18.0%. The growth seen throughout the projected period can be accredited to various factors such as cosmetic and aesthetic applications, new emerging therapies, increased usage in pediatric and geriatric populations, global health initiatives and point-of-care testing. Noteworthy developments during this period include the rise of smart microneedles, progress in material science, advancements in wearable technology, biodegradable materials, and continuous glucose monitoring.
Get your microneedle drug delivery systems market report here!
What key factors are fueling the growth of the microneedle drug delivery systems market?
The upsurge in research and the demand for vaccination procedures are anticipated to propel the growth of the microneedle drug delivery systems market. Microneedles are seen by researchers as an alternative injection method for vaccines that would cause no pain to the vaccine recipient. Initially, the microneedle patch vaccine technology was developed for influenza and measles, but it is now increasingly utilized for the delivery of the COVID-19 vaccine. As an example, in April 2024, the UK government’s net expenditure on research and development (R&D), without EU R&D budget contributions, upped to $17.01 billion (£15.5 billion) in 2022 from $15.37 billion (£14.0 billion) in 2021, showing a growth of 10.5%, according to the Office for National Statistics, a UK-based government organization. Including contributions to the EU R&D budget and knowledge transfer activities, the total net R&D expenditure climbed to $18.006 billion (£16.4 billion) in 2022, reflecting an 8.9% rise from $16.46 billion (£15.0 billion) in 2021. As such, the rise in research and the demand for vaccination procedures are propelling the microneedle drug delivery systems market forward.
How is the global microneedle drug delivery systems market divided into key segments?
The microneedle drug delivery systems market covered in this report is segmented –
1) By Technology: Hollow, Porous, Solid, Other Technologies
2) By Application: Drug Delivery, Vaccine Delivery, Other Applications
3) By End-User: Diagnostics Laboratories, Life Sciences, Research Laboratories, Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Hollow: Solid Hollow Microneedles, Coated Hollow Microneedles
2) By Porous: Porous Silicon Microneedles, Hydrogel-Based Porous Microneedles
3) By Solid: Solid Microneedles For Vaccination, Solid Microneedles For Drug Delivery
4) By Other Technologies: Dissolving Microneedles, Biodegradable Microneedles, Micro-Infusion Systems
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5338&type=smp
Who are the key firms paving the way for growth in the microneedle drug delivery systems market?
Major companies operating in the microneedle drug delivery systems market include 3M Company, Zosano Pharma Corporation, Becton-Dickinson Technologies, Nanopass Technologies, Corium Inc., Valeritas Inc., Microdermics, TheraJect Inc., LTS Lohmann Therapie-Systeme AG, BioSerenTach (BT), Sorrento Therapeutics, Debiotech, Raphas Co. Ltd., QuadMedicine, Snvia Co. Ltd., NanoBiosciences LLC, AdminMed nanoBioSciences LLC, Nitto Denko Corporation, MyLife Technologies, Innoture Medical Technology Limited, Phillips-Medisize Corporation, Stemedica Cell Technologies Inc., Candela Corporation, Dermaroller GmbH, Micropoint Technologies, Vaxess Technologies, Micron Biomedical Inc., Kindeva Drug Delivery, Gurnet Point Capital, Moonlight Therapeutics Inc., Cutanos, Kimberly-Clark Corp., Clearside BioMedical Inc.
Which trends are expected to transform the microneedle drug delivery systems market?
Leading corporations in the microneedle drug delivery sector are concentrating on product innovation like radiofrequency microneedle systems, with the goal of offering dependable services to their clientele. Utilizing a minimally invasive approach, a radiofrequency microneedle system merges microneedles with radiofrequency energy to boost drug delivery and spur the synthesis of collagen in the skin for both therapeutic and cosmetic benefits. Candela, an American medical aesthetics device firm, in February 2023 initiated the Profound Matrix system. This multi-purpose system integrates the Sublime, Sublative RF, and the cutting-edge Matrix Pro applicators. The Sublime and Sublative RF utilize bipolar radiofrequency (RF) technology, improving the condition of fine lines and wrinkles, while the Matrix Pro applicator is designed to regenerate and stimulate collagen production. It is equipped with a range of thin microneedles that deliver short-pulse RF energy to the skin, enhancing patient comfort, minimizing downtime, and boosting overall outcomes.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5338
What regions are contributing significantly to the growth of the microneedle drug delivery systems market?
North America was the largest region in the microneedle drug delivery systems market in 2024. Europe was the second-largest region in the microneedle drug delivery systems market analysis. The regions covered in the microneedle drug delivery systems market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Central Nervous System Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/central-nervous-system-drug-global-market-report
Hematology Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report
Musculoskeletal Disorders Drugs Global Market Report 2022
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
